Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Yakuodo Holdings Co., Ltd. ( (JP:7679) ) just unveiled an announcement.
For the nine months ended November 30, 2025, Yakuodo Holdings reported consolidated net sales of ¥123.6 billion, up 7.9% year on year, with operating profit edging up 1.6% to ¥4.65 billion and profit attributable to owners of parent essentially flat at ¥3.39 billion. While earnings growth was modest, the company’s total assets expanded to ¥96.2 billion and equity rose to ¥39.6 billion, though its equity ratio declined to 41.1%, indicating a greater asset base supported by relatively lower capital efficiency. The group maintained its dividend stance, having paid ¥28 per share in the year ended February 2025 and forecasting a slight increase to a total of ¥29 per share for the year ending February 2026, even as its full-year forecast anticipates higher sales but lower profits, reflecting cost pressures and a more challenging operating environment.
The most recent analyst rating on (JP:7679) stock is a Hold with a Yen2385.00 price target. To see the full list of analyst forecasts on Yakuodo Holdings Co., Ltd. stock, see the JP:7679 Stock Forecast page.
More about Yakuodo Holdings Co., Ltd.
Yakuodo Holdings Co., Ltd., listed on the Tokyo Stock Exchange, operates in Japan’s retail drugstore and pharmacy sector. The company focuses on dispensing pharmaceuticals and related healthcare and daily-use products, serving regional consumer markets through a chain-based business model.
Average Trading Volume: 34,728
Technical Sentiment Signal: Sell
Current Market Cap: Yen42.78B
For an in-depth examination of 7679 stock, go to TipRanks’ Overview page.